Abstract:The hepatic endoplasmic reticulum stress (ER stress) sustains non‐alcoholic fatty liver disease (NAFLD) putting hepatic de novo lipogenesis into a vicious cycle. Early studies from our group have shown that polyphenol‐rich extract of S. cumini leaf (HESc) improves NAFLD in monosodium L‐glutamate (MSG)‐obese rats. Thus, this study aimed to investigate the effects of HESc on lipid metabolism and ER stress markers in the liver of MSG‐obese mice. MSG‐obese mice were orally treated with HESc (Obese+HESc, 0,5 g/kg/day) for 4 weeks, whereas other MSG‐Obese and Lean mice received saline. Weight gain, food intake, feed efficiency and Lee index (LI) were measured for obesity development assessment. At the end of treatment, glucose (GTT) and insulin (ITT) tolerance tests were performed. Blood, white adipose tissues (WAT) and liver were collected upon euthanasia of anesthetized animals. Serum glucose (GL), triglycerides (TG), total cholesterol (TC), free fatty acids (FFA) and insulin levels were determined and used to calculate HOMA‐IR and TyG indexes. WAT was weighed and their lipolytic activity assessed. Hepatic tissue was used to determine the lipid profile and gene expression of markers associated to TG synthesis (SREBP1c, PPARs, FAS, SCD1 and DGAT2) and exportation (APOB, PDI and MTTP). Expression of ER stress‐related genes (ATF6, IRE1α, PERK, NRF2 and CHOP) were also measured. HESc reduced the body weight (12%), LI (6%) and WAT (20%) as compared to Obese non‐treated mice. GL, TG, insulin and FFA levels were diminished in 38, 37, 29 and 30%, respectively. HESc improved insulin sensitivity by reducing both HOMA‐IR (56%) and TyG (9%) indexes, meanwhile increased k ITT (87%). Lipolytic activity of Obese+HESc was increased in both basal (72%) and isoproterenol‐stimulated (42%) conditions. Total fat liver and TG content were reduced in 29 and 22%, respectively. HESc decreased the expression of PPARγ (35%), SREBP1c (52%), PPARα (56%), FAS (63%), DGAT2 (50%), ApoB (50%), MTTP (45%), PERK (66%) and NRF2 (50%), as compared to Obese non‐treated mice. On the other hand, hepatic expression of IRE1α, ATF6, PDI and CHOP genes did not change among groups. Therefore, our data suggest that HESc amelliorates NAFLD in MSG‐obese mice by improving insulin sensitivity and downregulating gene expression of hepatic lipogenesis markers, as well as PERK downstream pathway, an important lipogenic inducer of ER stress in the liver. Support or Funding Information FAPEMA, UFMA and CAPES

Germinated Soybean Embryo Extract Ameliorates Fatty Liver Injury in High-Fat Diet-Fed Obese Mice

Fermented Soybean Paste Attenuates Biogenic Amine-Induced Liver Damage in Obese Mice

Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice

Ethyl acetate fraction of oregano seed protects non-alcoholic fatty liver in high-fat diet-induced obese mice through modulation of Srebp-1c

A soy glycinin derived octapeptide protects against MCD diet induced non-alcoholic fatty liver disease in mice

Black Sesame Seeds Ethanol Extract Ameliorates Hepatic Lipid Accumulation, Oxidative Stress, and Insulin Resistance in Fructose-Induced Nonalcoholic Fatty Liver Disease.

Plantago Asiatica L. Seed Extract Improves Lipid Accumulation and Hyperglycemia in High-Fat Diet-Induced Obese Mice

The Influence of Emodin Succinyl Ethyl Ester on Non-alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice

Multi-omics Reveals That Green Pea (pisum Sativum L.) Hull Supplementation Ameliorates Non-Alcoholic Fatty Liver Disease Via the SHMT2/glycine/mTOR/PPAR-γ Signaling Pathway.

Synergistic effects of black ginseng and aged garlic extracts for the amelioration of nonalcoholic fatty liver disease (NAFLD) in mice

Multi-omics reveals green pea (Pisum sativum L.) hull supplementation ameliorates non-alcoholic fatty liver disease via shmt2/glycine/mTOR/PPAR-γ signaling pathway

Polyphenol‐Rich Extract of Syzygium cumini Leaf Reduces Non‐alcoholic Fatty Liver Disease in MSG‐obese Mice by a Joint Action on Insulin Resistance and Endoplasmic Reticulum Stress

Sesamin Attenuates Obesity-Associated Nonalcoholic Steatohepatitis in High-Fat and High-Fructose Diet-Fed Mice.

Fermented soybean powder containing Bacillus subtilis SJLH001 protects against obesity in mice by improving transport function and inhibiting angiogenesis

Soy Isoflavones Improve the Oxidative Stress Induced Hypothalamic Inflammation and Apoptosis in High Fat Diet-Induced Obese Male Mice Through PGC1-alpha Pathway.

Chemical Compositions before and after Lactic Acid Fermentation of Isoflavone-Enriched Soybean Leaves and their Anti-Obesity and Gut Microbiota Distribution Effects

Soy Isoflavones Ameliorate Fatty Acid Metabolism Of Visceral Adipose Tissue By Increasing The Ampk Activity In Male Rats With Diet-Induced Obesity (Dio)

Soybean soluble polysaccharides enhance bioavailability of genistein and its prevention against obesity and metabolic syndrome of mice with chronic high fat consumption.

Sesamin Ameliorates Hepatic Steatosis and Inflammation in Rats on A High-Fat Diet Via Lxr Alpha and Ppar Alpha

A Lard and Soybean Oil Mixture Alleviates Low-Fat–High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice

Oral Supplementation with Three Vegetable Oils Differing in Fatty Acid Composition Alleviates High-Fat Diet-Induced Obesity in Mice by Regulating Inflammation and Lipid Metabolism